A comparison of the National Institute for Health and Care Excellence (NICE) and European Association of Urology (EAU) guidelines for the assessment and management of urinary incontinence in women

Abstract

Objective:

The objective of this paper is to identify the similarities and key differences between the National Institute for Health and Care Excellence (NICE) and European Association of Urology (EAU) guidelines on the management of urinary incontinence (UI) in women.

Methods:

We reviewed the most recent iterations of both full guidelines to identify all key recommendations and their associated level/grade of evidence. Guidance on the management of urinary incontinence in men and neuropathic patients was excluded.

Results:

There is a significant overlap in the recommendations of both guidelines. Key differences include the indications for performing urodynamics, pharmacological agents in stress UI, the dose of botulinum toxin A (200 units by NICE, 100 units by EAU), the hierarchy of surgical options for primary stress UI and the role of the multi-disciplinary team (MDT).

Conclusion:

This review provides the various stakeholders involved in the management of female UI with a summary of the strength of evidence supporting the recommendations by these two key guidelines. We have provided an evidence-based framework to support clinical experience from which to base management decisions.

Keywords

Urinary incontinence guidelines urodynamics antimuscurinics urinary incontinence surgery

Get full access to this article

View all access options for this article.

References

Abrams

Cardozo

Fall

et al . The standardisation of terminology of lower urinary tract function. Neurourol Urodyn 2002; 21: 167–178.

British Association of Urological Surgeons. Incontinence of urine, http://www.baus.org.uk/patients/conditions/5/incontinence_of_urine (2017, accessed 5 February 2017).

National Collaborating Centre for Women’s and Children’s Health commissioned by the National Institute for Health and Care Excellence. Urinary incontinence in women: The management of urinary incontinence in women. London: Royal College of Obstetricians and Gynaecologists, 2013.

European Association of Urology. Urinary incontinence, http://uroweb.org/guideline/urinary-incontinence (2016, accessed 21 July 2017).

Brubaker

Shull

. EGGS for patient-centred outcomes. Int Urogynecol J Pelvic Floor Dysfunct 2005; 16: 171–173.

Jackson

Donovan

Brookes

et al . The Bristol Female Lower Urinary Tract Symptoms questionnaire: Development and psychometric testing. Br J Urol 1996; 77: 805–812.

Stothers

. Reliability, validity, and gender differences in the quality of life index of the SEAPI-QMM incontinence classification system. Neurourol Urodyn 2004; 23: 223–228.

Devillé

Yzermans

van Duijn

et al . The urine dipstick test useful to rule out infections. A meta-analysis of the accuracy. BMC Urol 2004; 4: 4.

Boscia

Abrutyn

Levison

et al . Pyuria and asymptomatic bacteriuria in elderly ambulatory women. Ann Intern Med 1989; 110: 404–405.

10.

Ouslander

Schapira

Schnelle

et al . Does eradicating bacteriuria affect the severity of chronic urinary incontinence in nursing home residents? Ann Intern Med 1995; 122: 749–754.

11.

Krhut

Zachoval

Smith

et al . Pad weight testing in the evaluation of urinary incontinence. Neurourol Urodyn 2014; 33: 507–510.

12.

Nager

Brubaker

Litman

et al . A randomized trial of urodynamic testing before stress-incontinence surgery. N Engl J Med 2012; 366: 1987–1997.

13.

Glazener

Lapitan

. Urodynamic studies for management of urinary incontinence in children and adults. Cochrane Database Syst Rev 2012; CD003195.

14.

Bryant

Dowell

Fairbrother

. Caffeine reduction education to improve urinary symptoms. Br J Nurs 2002; 11: 560–565.

15.

Bump

Sugerman

Fantl

et al . Obesity and lower urinary tract function in women: Effect of surgically induced weight loss. Am J Obstet and Gynecol 1992; 167: 392–397.

16.

Ahroni

Montgomery

Watkins

. Laparoscopic adjustable gastric banding: Weight loss, co-morbidities, medication usage and quality of life at one year. Obes Surg 2005; 15: 641–647.

17.

Fantl

Wyman

McClish

et al . Efficacy of bladder training in older women with urinary incontinence. JAMA 1991; 265: 609–613.

18.

Rai

Cody

Alhasso

et al . Anticholinergic drugs versus non-drug active therapies for non-neurogenic overactive bladder syndrome in adults. Cochrane Database Syst Rev 2012; CD003193.

19.

Imamura

Abrams

Bain

et al . Systematic review and economic modelling of the effectiveness and cost-effectiveness of non-surgical treatments for women with stress urinary incontinence. Health Technol Assess 2010; 14: 1–188; iii–iv.

20.

Boyle

Hay-Smith

Cody

et al . Pelvic floor muscle training for prevention and treatment of urinary and faecal incontinence in antenatal and postnatal women. Cochrane Database Syst Rev 2012; CD007471.

21.

National Institute for Health and Care Excellence (NICE). Mirabegron for treating symptoms of overactive bladder. London: National Institute for Health and Care Excellence: Clinical guidelines, 2013.

22.

Lose

Mattiasson

Walter

et al . Clinical experiences with desmopressin for long-term treatment of nocturia. J Urol 2004; 172: 1021–1025.

23.

Fleissig

Jenkins

Catt

et al . Multidisciplinary teams in cancer care: Are they effective in the UK? Lancet Oncol 2006; 7: 935–943.

24.

Taylor

Munro

Glynne-Jones

et al . Multidisciplinary team working in cancer: What is the evidence? BMJ 2010; 340: c951.

25.

Munro

. Multidisciplinary team meetings in cancer care: An idea whose time has gone? Clin Oncol (R Coll Radiol) 2015; 27: 728–731.

26.

Dmochowski

Chapple

Nitti

et al . Efficacy and safety of onabotulinumtoxin A for idiopathic overactive bladder: A double-blind, placebo controlled, randomized, dose ranging trial. J Urol 2010; 184: 2416–2422.

27.

Altaweel

Mokhtar

Rabah

. Prospective randomized trial of 100u vs 200u Botox in the treatment of idiopathic overactive bladder. Urol Ann 2011; 3: 66–70.

28.

Duthie

Vincent

Herbison

et al . Botulinum toxin injections for adults with overactive bladder syndrome. Cochrane Database Syst Rev 2011; CD005493.

29.

Nitti

Dmochowski

Herschorn

et al . OnabotulinumtoxinA for the treatment of patients with overactive bladder and urinary incontinence: Results of a phase 3, randomized, placebo controlled trial. J Urol 2013: 189: 2186–2193.

30.

Electronic Medicines Compendium. Botox 100 units. Summary of product characteristics, https://www.medicines.org.uk/emc/medicine/112 (2017, accessed 21 July 2017).

31.

Herbison

Arnold

. Sacral neuromodulation with implanted devices for urinary storage and voiding dysfunction in adults. Cochrane Database Syst Rev 2009; CD004202.

32.

Spinelli

Giardiello

Gerber

et al . New sacral neuromodulation lead for percutaneous implantation using local anesthesia: Description and ﬁrst experience. J Urol 2003; 170: 1905–1907.

33.

Biardeau

Chartier-Kastler

Rouprêt

et al . Risk of malignancy after augmentation cystoplasty: A systematic review. Neurourol Urodyn 2016; 35: 675–682.

34.

Leng

Blalock

Fredriksson

et al . Enterocystoplasty or detrusor myectomy? Comparison of indications and outcomes for bladder augmentation. J Urol 1999; 161: 758–763.

35.

Kuo

. Effectiveness of intravesical resiniferatoxin for anticholinergic treatment refractory detrusor overactivity due to nonspinal cord lesions. J Urol 2003; 170: 835–839.

36.

Apostolidis

Gonzales

Fowler

. Effect of intravesical resiniferatoxin (RTX) on lower urinary tract symptoms, urodynamic parameters, and quality of life of patients with urodynamic increased bladder sensation. Eur Urol 2006; 50: 1299–1305.

37.

Ogah

Cody

Rogerson

. Minimally invasive synthetic suburethral sling operations for stress urinary incontinence in women. Cochrane Database Syst Rev 2009; CD006375.

38.

Albo

Richter

Brubaker

et al . Burch colposuspension versus fascial sling to reduce urinary stress incontinence. N Engl J Med 2007; 356: 2143–2155.

39.

Lucas

Bosch

Burkhard

et al . EAU guidelines on surgical treatment of urinary incontinence. Eur Urol 2012; 62: 1118–1129.

40.

Rehman

Bezerra

Bruschini

et al . Traditional suburethral sling operations for urinary incontinence in women. Cochrane Database Syst Rev 2011; CD001754.

41.

Latthe

Singh

Foon

et al . Two routes of transobturator tape procedures in stress urinary incontinence: A meta-analysis with direct and indirect comparison of randomized trials. BJU Int 2010; 106: 68–76.

42.

Mostafa

Lim

Hopper

et al . Single-incision mini-slings versus standard midurethral slings in surgical management of female stress urinary incontinence: An updated systematic review and meta-analysis of effectiveness and complications. Eur Urol 2014; 65: 402–427.

43.

Maher

O’Reilly

Dwyer

et al . Pubovaginal sling versus transurethral Macroplastique for stress urinary incontinence and intrinsic sphincter deficiency: A prospective randomised controlled trial. BJOG 2005; 112: 797–801.

44.

Schulz

Nager

Stanton

et al . Bulking agents for stress urinary incontinence: Short-term results and complications in a randomized comparison of periurethral and transurethral injections. Int Urogynecol J Pelvic Floor Dysfunct 2004; 15: 261–265.

45.

Kuhn

Stadlmayr

Lengsfeld

et al . Where should bulking agents for female urodynamic stress incontinence be injected? Int Urogynecol J Pelvic Floor Dysfunct 2008; 19: 817–821.

46.

Amaye-Obu

Drutz

. Surgical management of recurrent stress urinary incontinence: A 12-year experience. Am J Obstet Gynecol 1999; 181: 1296–1307.